Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rank in Stocks #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Share Price
$0.21291741
Last synced: 2025-04-18
Market Cap
$12.07M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
KR
Trade PCL, Inc. (241820)

Category

Earnings for PCL, Inc. (241820)
Earnings in Sep 2025 TTM: $-33.90M
According to PCL, Inc. latest financial reports the company's current earnings are $-33.90M. In 2023 the company made an earning of $-15.73M, a decrease compared to its 2022 earnings that were of $-3.18M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for PCL, Inc. from 2015 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-33.90M -5.68%
2024 $-35.94M 128.48%
2023 $-15.73M 394.91%
2022 $-3.18M -88.07%
2021 $-26.64M -248.25%
2020 $17.97M -360.49%
2019 $-6.90M 33.10%
2018 $-5.18M 42.76%
2017 $-3.63M 87.03%
2016 $-1.94M 22.38%
2015 $-1.59M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$7.51B -22,254.56%
US
$5.15B -15,284.62%
US
$5.56B -16,508.71%
IE
$3.86B -11,488.46%
US
$1.42B -4,281.37%
US